StockData

Zhengye Biotechnology Holding Ltd (ZYBT) KPIs and segments

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Zhengye Biotechnology's business

Zhengye Biotechnology's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
FY2025
FY2024
FY2023
FY2022
Swine vaccines(CN¥M)
90.1158189236
Distribution network(CN¥M)
61.559.949.647.8
Direct sales channel(CN¥M)
51.9122160207
Other vaccines(CN¥M)
13.713.17.308.29
Poultry vaccines(CN¥M)
12.515.515.416.4
Government tender and procurement(CN¥M)
2.964.732.505.10

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-04-28.

See a number that looks wrong?